DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in DiaMedica Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +9 vs. Q2 2024
- Shares held
- 5.58M
- +622.6K (+12.6%) vs. Q2 2024
- Total value
- $23.3M
- +$8.70M (+59.5%) vs. Q2 2024
- New holders
- 13
- 9 more added
- Sold out
- 4
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 27 | $113 | 0.00% | +27 | New |
| Cornerstone Planning Group LLC | 80 | $346 | 0.00% | +80 | New |
| Bank of America Corp | 213 | $892 | 0.00% | +30+16.4% | Added |
| Royal Bank of Canada | 805 | $3.00K | 0.00% | −251−23.8% | Reduced |
| Legend Financial Advisors, Inc. | 1,000 | $4.19K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,055 | $4.42K | 0.00% | −1,000−48.7% | Reduced |
| TD Waterhouse Canada Inc. | 1,070 | $4.45K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,118 | $4.68K | 0.00% | −770−40.8% | Reduced |
| Naples Money Management LLC | 2,068 | $8.66K | 0.01% | −910−30.6% | Reduced |
| Cubist Systematic Strategies, LLC | 3,263 | $13.7K | 0.00% | +3,263 | New |
| Simplex Trading, LLC | 3,662 | $15.0K | 0.00% | +3,662 | New |
| US Bancorp | 4,335 | $18.2K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 4,824 | $20.2K | 0.00% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 9,498 | $39.8K | 0.01% | +9,498 | New |
| Magnolia Capital Advisors LLC | 10,000 | $41.9K | 0.02% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 11,520 | $48.3K | 0.00% | +11,520 | New |
| Citadel Advisors LLC | 11,831 | $49.6K | 0.00% | +3,418+40.6% | Added |
| UBS Group AG | 12,739 | $53.4K | 0.00% | +12,739 | New |
| Charles Schwab Investment Management Inc | 13,251 | $55.5K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 16,500 | $69.1K | 0.00% | +1,300+8.6% | Added |
| Dimensional Fund Advisors LP | 16,959 | $71.1K | 0.00% | 00.0% | Unchanged |
| Stonebridge Capital Advisors LLC | 17,500 | $73.3K | 0.01% | −2,500−12.5% | Reduced |
| Citigroup Inc | 22,097 | $92.6K | 0.00% | +22,097 | New |
| Jefferies Financial Group Inc. | 26,000 | $108.9K | 0.00% | +26,000 | New |
| Ronald Blue Trust, Inc. | 44,247 | $130.5K | 0.00% | +44,247 | New |
| Millennium Management LLC | 33,690 | $141.2K | 0.00% | +33,690 | New |
| Catalyst Financial Partners LLC | 38,457 | $161.1K | 0.03% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 52,089 | $218.3K | 0.00% | +52,089 | New |
| State Street Corp | 68,729 | $288.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 101,450 | $425.1K | 0.00% | +58,077+133.9% | Added |
| BlackRock, Inc. | 107,790 | $451.6K | 0.00% | +107,790 | New |
| Morgan Stanley | 110,016 | $461.0K | 0.00% | +23,816+27.6% | Added |
| Northern Trust Corp | 120,290 | $504.0K | 0.00% | −99−0.1% | Reduced |
| LPL Financial LLC | 140,500 | $588.7K | 0.00% | +123,000+702.9% | Added |
| Geode Capital Management, LLC | 306,958 | $1.29M | 0.00% | +70,070+29.6% | Added |
| Bleichroeder LP | 382,317 | $1.60M | 0.43% | 00.0% | Unchanged |
| Paragon Associates & Paragon Associates II Joint Venture | 482,614 | $2.02M | 3.63% | 00.0% | Unchanged |
| First Manhattan Co | 839,081 | $3.52M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,049,029 | $4.40M | 0.00% | +31,627+3.1% | Added |
| Cooperman Leon G | 1,511,739 | $6.33M | 0.27% | +111,739+8.0% | Added |
| Aristides Capital LLC | 0 | $0 | 0.00% | −106,333−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,091−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |